| Patient | Alan Turing |
|---|---|
| Date of birth | 1912-06-23 |
| Identifiers | MRN HR-ML007-SYN-TD; SSN (made up) 000-07-6290 |
| Document date | 1953-04-14 |
| Author | Rupert Hallam, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new-patient primary care visit for breast enlargement, low libido, and low mood after a year of high-dose estrogen given without his consent. [S]
PHQ-9: 15; GAD-7: 8; AUDIT-C: 2; Total testosterone: 112 ng/dL (low); Estradiol: 148 pg/mL (high); LH: 0.3 m[IU]/mL (low); FSH: 0.4 m[IU]/mL (low); SHBG: 88 nmol/L (high); Prolactin: 21.6 ng/mL (high); hCG (beta subunit): 1 m[IU]/mL; AFP: 2.6 ng/mL; ALT: 22 U/L; AST: 24 U/L; Total bilirubin: 0.6 mg/dL; Creatinine: 0.96 mg/dL; eGFR: 102 mL/min/1.73 m²; TSH: 1.9 mIU/L; Hemoglobin: 13 g/dL (low); 25-hydroxyvitamin D: 22 ng/mL (low). [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1953-04-14 | Body height | 178 | cm | S |
| 1953-04-14 | Body weight | 71.4 | kg | S |
| 1953-04-14 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1953-04-14 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1953-04-14 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1953-04-14 | Heart rate | 64 | /min | S |
| 1953-04-14 | Respiratory rate | 14 | /min | S |
| 1953-04-14 | Body temperature | 36.6 | Cel | S |
| 1953-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1953-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 15 | {score} | S | ||
| 1953-04-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 1953-04-14 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 1953-04-14 | Testosterone [Mass/volume] in Serum or Plasma | 112 | ng/dL | 264-916 ng/dL | Low | S |
| 1953-04-14 | Estradiol (E2) [Mass/volume] in Serum or Plasma | 148 | pg/mL | 7.6-42.6 pg/mL | High | S |
| 1953-04-14 | Lutropin [Units/volume] in Serum or Plasma | 0.3 | m[IU]/mL | 1.7-8.6 m[IU]/mL | Low | S |
| 1953-04-14 | Follitropin [Units/volume] in Serum or Plasma | 0.4 | m[IU]/mL | 1.5-12.4 m[IU]/mL | Low | S |
| 1953-04-14 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma | 88 | nmol/L | 16.5-55.9 nmol/L | High | S |
| 1953-04-14 | Prolactin [Mass/volume] in Serum or Plasma | 21.6 | ng/mL | 4-15.2 ng/mL | High | S |
| 1953-04-14 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | 1 | m[IU]/mL | <=3 m[IU]/mL | Normal | S |
| 1953-04-14 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | 2.6 | ng/mL | <=8.3 ng/mL | Normal | S |
| 1953-04-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 1953-04-14 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 8-48 U/L | Normal | S |
| 1953-04-14 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1953-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1953-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1948)/1.73 sq M | 102 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1953-04-14 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1953-04-14 | Hemoglobin [Mass/volume] in Blood | 13 | g/dL | 13.2-16.6 g/dL | Low | S |
| 1953-04-14 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | 30-100 ng/mL | Low | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1953-04-14 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bilateral gynecomastia, tender, about 4 cm of firm glandular tissue behind each nipple, after a year of high-dose estrogen; synthetic modern diagnosis linked to the documented breast growth from his hormone treatment | active | confirmed | N62 | S — Synthetic modern diagnosis. That the hormone treatment caused breast growth is reported in the sources (D, mentioned once in his own words); the examination findings are synthetic. |
| Suppressed testosterone and gonadotropins from exogenous estrogen (drug-induced hypogonadotropic hypogonadism), with low libido, erectile difficulty, and fatigue | active | confirmed | E23.1 | S — Synthetic consequence of high-dose estrogen, which suppresses LH and FSH; recovery is expected once it stops. |
| Adverse effects of high-dose estrogen given for a year without free and informed consent, as the alternative to imprisonment | active | confirmed | T38.5X5A | S — Synthetic modern framing of the documented hormone treatment imposed after his conviction (D); in the modern episode it is recorded as iatrogenic harm. |
| Major depressive disorder, single episode, moderate, after prosecution and coerced hormone treatment; synthetic modern diagnosis (no depression diagnosis is documented in his lifetime) | active | confirmed | F32.1 | S — Synthetic modern diagnosis. That he sought Jungian analysis after the trial is documented (D); calling his state then a depressive illness is a retrospective interpretation (R). |
| Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding of the bone-health workup. |